Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 52, 2014, Pages 18685-18690

  Gobbetti, Thomas ^a   Coldewey, Sina M ^a,b   Chen, Jianmin ^a   McArthur, Simon ^a   Le Faouder, Pauline ^c   Cenac, Nicolas ^d   Flower, Roderick J ^a   Thiemermann, Christoph ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c University Hospital of Toulouse   (France)

^d France   (France)

Author keywords

ALX; Annexin peptide; Cardiac dysfunction; Resolution of inflammation; Therapeutic innovation

Indexed keywords

ALANINE AMINOTRANSFERASE; ANALGESIC AGENT; ASPARTATE AMINOTRANSFERASE; CR AC 2 50 PEPTIDE; CXCL1 CHEMOKINE; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2 3; FORMYLPEPTIDE RECEPTOR LIKE 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTECTIVE AGENT; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; CXCL1 PROTEIN, MOUSE; FORMYL PEPTIDE RECEPTOR 2, MOUSE; HSH2 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTEREMIA; BACTERIAL CLEARANCE; BACTERIUM COLONY; BODY FLUID; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; GENE ACTIVATION; GENOTYPE; GRANULOCYTE; HEART DISEASE; HEART FUNCTION; HEART PROTECTION; HYPOTHERMIA; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; LIVER DYSFUNCTION; LIVER PROTECTION; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM LAVAGE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; SEPSIS; T LYMPHOCYTE; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PERITONEUM; SIGNAL TRANSDUCTION; TIME;

ANIMALIA; MURINAE; MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CHEMOKINE CCL2; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; GRANULOCYTES; HUMANS; MICE; MICE, KNOCKOUT; MONOCYTES; PERITONEUM; RECEPTORS, FORMYL PEPTIDE; SEPSIS; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923109396     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1410938111     Document Type: Article

References (50)

1. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P (2013) Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 93(3):329-342.
2. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA (2009) The sepsis seesaw: Tilting toward immunosuppression. Nat Med 15(5):496-497.
3. Abraham E, et al. (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 273(12):934-941.
4. Deans KJ, Haley M, Natanson C, Eichacker PQ, Minneci PC (2005) Novel therapies for sepsis: A review. J Trauma 58(4):867-874.
5. Serhan CN (2011) The resolution of inflammation: The devil in the flask and in the details. FASEB J 25(5):1441-1448.
6. Ortega-Gómez A, Perretti M, Soehnlein O (2013) Resolution of inflammation: An integrated view. EMBO Mol Med 5(5):661-674.
7. Serhan CN (2010) Novel lipid mediators and resolution mechanisms in acute inflammation: To resolve or not? Am J Pathol 177(4):1576-1591.
8. Damazo AS, et al. (2005) Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol 166(6):1607-1617.
9. Walker J, et al. (2011) Lipoxin a 4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 36(4):410-416.
10. Spite M, et al. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461(7268):1287-1291.
11. Ye RD, et al. (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61(2):119-161.
12. Dufton N, et al. (2010) Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 184(5):2611-2619.
13. Brancaleone V, et al. (2013) A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood 122(4):608-617.
14. Brancaleone V, et al. (2011) Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol 186(8):4905-4914.
15. Cooray SN, et al. (2013) Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc Natl Acad Sci USA 110(45):18232-18237.
16. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420(6917):885-891.
17. Scannell M, et al. (2007) Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178(7):4595-4605.
18. Dalli J, et al. (2013) Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J Immunol 190(12):6478-6487.
19. Bone RC, et al.; The ACCP/SCCM Consensus Conference Committee; American College of Chest Physicians/Society of Critical Care Medicine (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101(6):1644-1655.
20. Bone RC, et al. (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317(11):653-658.
21. Ziegler EJ, et al. (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 324(7):429-436.
22. Fisher CJ, Jr, et al.; The Soluble TNF Receptor Sepsis Study Group (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 334(26):1697-1702.
23. Fisher CJ, Jr, et al.; IL-1RA Sepsis Syndrome Study Group (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 22(1):12-21.
24. Dejager L, Pinheiro I, Dejonckheere E, Libert C (2011) Cecal ligation and puncture: The gold standard model for polymicrobial sepsis? Trends Microbiol 19(4):198-208.
25. Rivers E, et al.; Early Goal-Directed Therapy Collaborative Group (2001) Early goaldirected therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368-1377.
26. Coldewey SM, Rogazzo M, Collino M, Patel NS, Thiemermann C (2013) Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse. Dis Model Mech 6(4):1031-1042.
27. Coldewey SM, et al. (2013) Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β -common receptor. Kidney Int 84(3): 482-490.
28. Chen F, et al. (2014) Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response. Eur J Clin Microbiol Infect Dis 33(3):457-464.
29. Fullerton JN, O'Brien AJ, Gilroy DW (2013) Pathways mediating resolution of inflammation: When enough is too much. J Pathol 231(1):8-20.
30. Maddox JF, Serhan CN (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: Selective inactivation by dehydrogenation and reduction. J Exp Med 183(1):137-146.
31. Wantha S, et al. (2013) Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res 112(5):792-801.
32. Yona S, et al. (2006) Impaired phagocytic mechanism in annexin 1 null macrophages. Br J Pharmacol 148(4):469-477.
33. Filep JG (2013) Biasing the lipoxin A4/formyl peptide receptor 2 pushes inflammatory resolution. Proc Natl Acad Sci USA 110(45):18033-18034.
34. Maderna P, et al. (2010) FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis. FASEB J 24(11): 4240-4249.
35. Rudiger A, Singer M (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35(6):1599-1608.
36. Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345(8):588-595.
37. Osuchowski MF, Welch K, Siddiqui J, Remick DG (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177(3):1967-1974.
38. Khadour FH, et al. (2002) Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol 283(3):H1108-H1115.
39. Barth E, et al. (2006) Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 34(2):307-313.
40. Mayadas TN, Cullere X, Lowell CA (2014) The multifaceted functions of neutrophils. Annu Rev Pathol 9:181-218.
41. Serhan CN, Savill J (2005) Resolution of inflammation: The beginning programs the end. Nat Immunol 6(12):1191-1197.
42. O'Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B (2004) Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum 50(6):1788-1799.
43. Iribarren P, et al. (2007) Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia. Neurobiol Dis 27(1):90-98.
44. Ritchie RH, Gordon JM, Woodman OL, Cao AH, Dusting GJ (2005) Annexin-1 peptide Anx-1(2-26) protects adult rat cardiac myocytes from cellular injury induced by simulated ischaemia. Br J Pharmacol 145(4):495-502.
45. Ritchie RH, Sun X, Bilszta JL, Gulluyan LM, Dusting GJ (2003) Cardioprotective actions of an N-terminal fragment of annexin-1 in rat myocardium in vitro. Eur J Pharmacol 461(2-3):171-179.
46. Kim SD, et al. (2010) The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection. J Immunol 185(7):4302-4310. 47.
47. Norling LV, Perretti M (2013) Control of myeloid cell trafficking in resolution. J Innate Immun 5(4):367-376.
48. Kapoor A, et al. (2010) Protective role of peroxisome proliferator-activated receptor- β/δ in septic shock. Am J Respir Crit Care Med 182(12):1506-1515.
49. Le Faouder P, et al. (2013) LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites. J Chromatogr B Analyt Technol Biomed Life Sci 932:123-133.
50. Perretti M, Solito E, Parente L (1992) Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions 35(1-2):71-78.